You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 257 No. 8, February 27, 1987 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Brief Reports
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Transmission of Hepatitis B Virus by Artificial Insemination

William R. Berry, MD; Ray L. Gottesfeld, MD; Harvey J. Alter, MD; John M. Vierling, MD

JAMA. 1987;257(8):1079-1081.


Abstract

Although the capacity for transmission of hepatitis B infection by semen is well recognized, the potential for transmission by artificial insemination remains theoretical. Currently, screening of semen donors for hepatitis B virus infection is not standard practice. We saw a case of acute viral hepatitis B in a woman following artificial insemination with semen from a donor subsequently found to be positive for hepatitis B surface antigen (HBsAg). Both the donor serum and semen contained HBsAg and hepatitis B e antigen, and the HBsAg subtype was identical to that of the patient. Documentation of hepatitis B virus transmission by artificial insemination indicates that HBsAg screening of semen donors should be routine practice.

(JAMA 1987;257:1079-1081)



Author Affiliations

From the Departments of Medicine, University of Colorado Health Sciences Center and Denver Veterans Administration Medical Center (Drs Berry and Vierling); the Department of Obstetrics and Gynecology, University of Colorado Health Sciences Center and Rose Medical Center, Denver (Dr Gottesfeld); and the Immunology Section, Department of Transfusion Medicine, National Institutes of Health, Bethesda, Md (Dr Alter).


Footnotes

Reprint requests to Gastroenterology Division 111E, Veterans Administration Medical Center, 1055 Clermont St, Denver, CO 80220 (Dr Vierling).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk of contamination of germplasm during cryopreservation and cryobanking in IVF units
Bielanski and Vajta
Hum Reprod 2009;24:2457-2467.
ABSTRACT | FULL TEXT  

Medically assisted reproduction in the presence of chronic viral diseases
Englert et al.
Hum Reprod Update 2004;10:149-162.
ABSTRACT | FULL TEXT  

HIV Transmission Through Donor Artificial Insemination
Araneta et al.
JAMA 1995;273:854-858.
ABSTRACT  

Artificial Insemination by Donor: Safety and Secrecy
Guinan
JAMA 1995;273:890-891.
ABSTRACT  

Semen Banking, Organ and Tissue Transplantation, and HIV Antibody Testing
JAMA 1988;259:1301-1301.
 

Leads From the MMWR
JAMA 1987;258:308-311.
 

Semen Donors as the Source of Sexually Transmitted Diseases in Artificially Inseminated Women: The Saga Unfolds
Mascola and Guinan
JAMA 1987;257:1093-1094.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.